The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET/AGO-B-062, NCT 05559411).
 
Maggie Banys-Paluchowski
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; Canon Medical System; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Resitu; Roche; Samsung; Seagen; Sirius Medical; Stemline Therapeutics; Syantra
Consulting or Advisory Role - Amgen; AstraZeneca; Canon Medical System; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Roche; Samsung; Seagen; Sirius Medical
Speakers' Bureau - Amgen; AstraZeneca; Canon Medical System; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Roche; Samsung; Seagen; Sirius Medical
Research Funding - Endomagnetics (Inst); Exact Sciences; Hologic; mammotome (Inst); Merit Medical Systems (Inst); Sirius Medical
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Lilly; Pfizer
 
Nina Ditsch
Honoraria - AstraZeneca, Daiichi-Sankyo, Exact Sciences, Pierre-Fabre, pfm medical ag, Roche, Lilly, Pfizer, Gilead, Novartis, ClinSol/Onkowissen, Gapinsaat, Aurikamed, Menarini-Stemline, Uni Würzburg, VHS
Consulting or Advisory Role - Gilead, Lilly, MSD, Novartis, Pfizer, Roche, Seagen
Research Funding - Gilead, BZKF
Travel, Accommodations, Expenses - AGO, KUKUM, UKA, Lilly, Pfizer, BMMC, Aurikamed, Uni Würzburg, Menarini-Stemline, AstraZeneca, Kelcon, Gilead, COCS, pfm-medical, Novartis, Daiichi-Sankyo, RG-Kongress, WSG-Studiengruppe, NCT-WERA, Roche
Other Relationship - Onkowissen, Jörg Eickeler Kongress, if-Kongress
 
Jai Min Ryu
No Relationships to Disclose
 
Neslihan Cabioglu
No Relationships to Disclose
 
Guldeniz Karadeniz Cakmak
No Relationships to Disclose
 
Tove Tvedskov
Honoraria - Astra Zenica and MSD in 2024
 
Dawid Murawa
No Relationships to Disclose
 
Severine Alran
No Relationships to Disclose
 
Oreste Gentilini
Consulting or Advisory Role - AstraZeneca; Bayer; BD Medical; Lilly; MSD Oncology
 
Rosa Di Micco
No Relationships to Disclose
 
James Harvey
No Relationships to Disclose
 
Yazan Masannat
No Relationships to Disclose
 
Lina Pankratjevaite
No Relationships to Disclose
 
Maria Luisa Gasparri
No Relationships to Disclose
 
Jana de Boniface
No Relationships to Disclose
 
Andreas Karakatsanis
Honoraria - AstraZeneca (Inst); Elsevier; Endomag (Inst); Pfizer (Inst)
Consulting or Advisory Role - Resitu
 
Walter Weber
Stock and Other Ownership Interests - Oncoplastic Breast Consortium
Honoraria - MSD
Research Funding - Agendia (Inst)
 
Natalia Krawczyk
No Relationships to Disclose
 
Steffi Hartmann
No Relationships to Disclose
 
Thorsten Kühn
Honoraria - Endomag; MSD; Sirius Pintuition
 
MELODY Study Group
No Relationships to Disclose